Evidence map›Paper›PMID 40711948›Full record

ArticleAIDS care2025

Using epidemiological data to explore the impact of mental health and substance use disorder treatment facilities and family planning clinic availability on pre-exposure prophylaxis use for women in the U.S.

Dion C Allen, Silvia E Rabionet, Sannisha K Dale, Carmen D Zorrilla, Georgina Silva-Suarez, Ioana Popovici

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dion C AllenDepartment of Sociobehavioral and Administrative Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.ORCID 0000-0002-0662-7192
Silvia E RabionetDepartment of Sociobehavioral and Administrative Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.
Sannisha K DaleCulturally-Focused HIV Advancements through the Next Generation for Equity (CHANGE) Training Program, University of Miami, Miami, FL, USA.
Carmen D ZorrillaObstetrics and Gynecology, Maternal-Infant Studies Center, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, Puerto Rico.
Georgina Silva-SuarezDepartment of Sociobehavioral and Administrative Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.
Ioana PopoviciDepartment of Sociobehavioral and Administrative Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.

Funding

Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yuhua Bao · 2015 to 2026
$20.7M
Five Point Initiative: A Cluster Randomized Trial of a Bundled Implementation Strategy to Address the HIV Epidemic in Black CommunitiesR01MH134269 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI Sannisha K Dale · 2023 to 2026
$4.5M
University of Puerto Rico Mentoring Institute for HIV Mental Health ResearchR25MH083617 · NIMH · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI ZORRILLA, CARMEN D · 2008 to 2020
$3.7M
Understanding Intersectional Discrimination and Adversities among Black Queer Women Living with HIVR01MH121194 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI DALE, SANNISHA K. · 2021 to 2024
$2.8M
Culturally-focused HIV Advancements through the Next Generation for Equity (CHANGE) Training ProgramT32MH126772 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DALE, SANNISHA K, FEASTER, DANIEL J · 2021 to 2025
$1.1M
NIDA NIH HHS P30 DA040500NIMH NIH HHS R01 MH121194NIMH NIH HHS R01 MH134269NIMH NIH HHS R25 MH083617NIMH NIH HHS T32 MH126772
6 · The paper itself

Abstract

Ending the HIV epidemic by 2030 is partly dependent on preexposure prophylaxis (PrEP), but usage has been markedly low among women. This study sought to determine if access to mental health and substance use disorder treatment, and family planning clinics have an impact on women's PrEP uptake. Using epidemiological data from publicly available data sources, we employed a difference-in-differences design to quantify the effect of the availability of these facilities on PrEP rate and PrEP-to-need ratio across all 50 states. We found that mental health and substance use disorder treatment had a small effect on PrEP rate for males 0.9% (0.888), but there was no effect on female PrEP outcomes. The availability of family planning clinics was found to be associated with an 8.1% (-0.664) decrease in PrEP rate among females. We concluded that PrEP is not being adequately implemented in mental health and substance use disorder treatment, and family planning clinics, suggesting missed opportunities. These facilities are excellent venues for promoting PrEP adoption as they already reach women susceptible to HIV. The focus should be on embedding PrEP-related care into existing standards of care in these settings to increase PrEP uptake among women who would benefit from PrEP.

Indexed as

Anti-HIV AgentsFamily Planning ServicesHealth Services AccessibilityHIV InfectionsMental DisordersMental Health ServicesPre-Exposure ProphylaxisSubstance-Related DisordersAdultFemaleHumansMaleMiddle AgedUnited StatesAnti-HIV Agentsfamily planning clinicsHIV preventionPrEPSDG 10: Reduced inequalitiesSDG 3: Good health and well-beingSDG 5: Gender equalitysubstance use treatmentwomen

Identifiers

PMID40711948
PMCPMC13487786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.